December 16, 2010

View this email as a web page
December 16, 2010 HIV/AIDS Monitor: Tracking AIDS Effectiveness

OF NOTE THIS WEEK

Earlier this week the Global Fund announced the creation of a new Dow Jones Index, called the Dow Jones Global Fund 50 Index. According to the press release, the index will measure the performance of the largest companies that support the Global Fund's mission, with a portion of revenues generated through the licensing of the index going directly to the Global Fund. Michel Kazatchkine, Executive Director of the Global Fund, expressed satisfaction in this collaboration. Not only will the partnership "provide the financial community with incentives to participate in innovative financing of health for development", he said, but it will also help the Global Fund "strengthen [their] engagement with the private sector and bring the power of financial markets to help save lives." This partnership is the result of a memorandum signed earlier this year between the Global Fund and the Dow Jones Index.

NEWS AND HIGHLIGHTS FROM THE DONORS

  • United States signs partnership frameworks on HIV/AIDS with South Africa and Botswana
  • Ambassador Goosby blogs on advancing global health partnerships at European Development Days
  • Dow Jones Indexes and the Global Fund launch the Dow Jones Global Fund 50 Index
  • The Global Fund proposes joint action to prevent theft of medicines
  • The Global Fund approves US$1.7 billion in new grants

OTHER NEWS AND HIGHLIGHTS

RECENT CGD HEALTH POLICY BLOGS

HIV/AIDS MONITOR RECOMMENDATIONS AND POLICY IMPACT

  • The HIV/AIDS Monitor has been tracking the policy changes among PEPFAR, the Global Fund and the World Bank MAP related to the recommendations that have come out of our research. Explore these changes using our interactive flash tool.

This email was sent to %%emailaddr%%
This email was sent by: %%Member_Busname%%
%%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%
Tel 202.416.4000 | Fax 202.416.7050


MANAGE SUBSCRIPTIONS | ABOUT | INVEST | CONTACT